Leading the Way in Life Science Technologies

GEN Exclusives

More »

November 15, Vol. 35, No. 20

  • Feature Articles

    • Cell-Free DNA Prospecting Starts to Pan Out
    • Lisa Heiden
    • With all the buzz surrounding liquid biopsies, people might think circulating cell-free DNA (cfDNA) is a new discovery Not so, says Iwijn De Vlaminck, PhD, assistant professor of biomedical engineering, Cornell University: “cfDNA was actually discovered in the 1940’s, even ... more »
    • GEN Roundup: Optimizing Your ADME/Tox Operations
    • Before a new prescription medicine gains marketing approval, it typically goes through a development process that lasts at least a decade Moreover, according to the Tufts Center for the Study of Drug Development, the costs can exceed $25 billion To raise the ... more »
    • Promises, Promises, and Cell Lines
    • Angelo DePalma
    • According to a 2013 report from the American Association for the Advancement of Science, $115 billion is spent annually in the United States on life science research Fifty percent of this total is spent on preclinical research, half of which—$28 ... more »